MedPath

nani Formulation in the management of Urinary Incontinence

Phase 2
Conditions
Health Condition 1: null- stress Urinary incontinence
Registration Number
CTRI/2018/04/012977
Lead Sponsor
uqman Unani Medical College Hospital and Research Centre
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Open to Recruitment
Sex
Not specified
Target Recruitment
40
Inclusion Criteria

Patients of SUI clinically assessed will be included in the study after obtaining their voluntary consent

Exclusion Criteria

Pregnant and lactating women

Women on OCPs

Patients with 3rd and 4th degree genital prolapse

history of systemic illnesses, endocrinal diseases and malignancies

history ofany pharmacological intervention within 3 months and have had surgical intervention for SUI.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Reduction in the number of incontinent episode assessed by bladder diary. <br/ ><br>Reduction in ICIQ-SF score. <br/ ><br>Timepoint: 60days <br/ ><br>
Secondary Outcome Measures
NameTimeMethod
Pelvic floor muscle strength assessed by Modified Oxford Grading Scale. <br/ ><br>Stress test <br/ ><br>Timepoint: 60days
© Copyright 2025. All Rights Reserved by MedPath